IGF-1 LR3 Chemistry: The Long-Arg3 Analog
A bench-level reference sheet on what the Long-Arg3 edits do to IGF-1, why an 83-residue disulfide-folded protein is expressed rather than synthesized, and what to read off the sequence before keeping one as a reference standard.
Sequence and Structure
IGF-1 LR3 is an engineered variant of human insulin-like growth factor 1. Native IGF-1 is a single-chain, 70-residue protein folded by three intramolecular disulfide bonds into a compact, insulin-like domain. The LR3 analog keeps that folded core but carries two deliberate edits: a 13-residue extension added to the N-terminus and an arginine-for-glutamic-acid substitution at position 3. Together those changes give an 83-residue chain, which is the figure to keep in mind when reading a mass result.
The name is a literal description of the molecule. "LR3" reads as Long, Arg, position 3, so the analog is best understood as native IGF-1 plus an N-terminal tail and a single charge-altering point substitution. The three disulfide bonds remain the structural feature that matters most for handling, because the protein is only the intended molecule when those bonds are paired correctly. Reading the sequence as a folded protein rather than a flat string is the right mental model for everything that follows.
Origin and the IGF Family
IGF-1 LR3 sits in the insulin-like growth factor family, a small group of single-chain proteins that share the insulin fold and its disulfide architecture. The family resemblance is structural: native IGF-1, the truncated IGF-1 DES variant, and IGF-2 all fold around the same conserved core, which is why they tend to respond to the same expression and analytical methods. Treating them as a family makes it easier to anticipate how a new entry will behave on the column and in the freezer.
What distinguishes IGF-1 LR3 within that family is purely the engineering. The native sequence is the reference point; the analog is the native fold carrying an N-terminal extension and a charge change designed to alter how the protein associates with its binding partners. For a research chemist the practical takeaway is that the LR3 edits change surface chemistry and solubility without rewriting the folded core, so the molecule behaves like an IGF protein with a longer, more basic N-terminus.
Why IGF-1 LR3 Is Expressed, Not Synthesized
At 83 residues with three disulfide bonds, IGF-1 LR3 is past the practical reach of solid-phase peptide synthesis and is produced instead by recombinant expression. A gene encoding the LR3 sequence is introduced into a host cell, the cell expresses the protein, and the material is then recovered from the culture. This is a different manufacturing route from the shorter peptides in the catalog, many of which are assembled by Fmoc solid-phase synthesis; the length and the disulfide count are what push IGF proteins toward expression.
The step that defines the chemistry is folding. Freshly expressed chain often has to be oxidatively refolded so the three disulfide bonds pair into the single correct pattern rather than one of the many mispaired alternatives. That refold, followed by chromatographic purification, is where a recombinant IGF preparation is made or lost, because a correctly folded molecule and a scrambled-disulfide isomer have the same amino acid composition but very different behavior. The N-terminal extension and the Arg3 substitution are encoded in the gene, so they are present from the first expressed chain rather than added in a later coupling.
Characterization
Identity and purity for IGF-1 LR3 are established with the same two complementary tools used across the reference catalog. Reversed-phase HPLC reports the purity figure, the percentage of total peak area attributable to the target protein, and it separates the main product from closely related species such as truncation products or misfolded isomers. Mass spectrometry confirms identity by matching the measured mass to the expected mass for the 83-residue, correctly disulfide-bonded analog.
Reading these together matters more for a folded protein than for a short linear peptide. An HPLC purity number describes how much of the sample is the intended molecule relative to other UV-absorbing species, while the mass result confirms that the main peak is in fact the right protein at the right oxidation state rather than a same-mass scrambled isomer. Both pieces of information describe the chemistry of a given preparation, and a research chemist should expect to interpret them together rather than in isolation.
Stability and Storage
As lyophilized powder, IGF-1 LR3 is comparatively stable when kept cold, dry, and out of light. Long-term storage of the dry solid is typically at freezer temperatures, with the container protected from moisture so the hygroscopic powder does not pick up water on opening. Allowing a sealed vial to reach room temperature before it is opened helps avoid condensation on the cold contents, which matters for a disulfide-folded protein that is sensitive to its handling environment.
Once reconstituted, the working solution is far less forgiving. Proteins in solution are subject to hydrolysis, oxidation, surface adsorption, and disulfide scrambling, so reconstituted material is generally held cold and used within a short window, with freeze-thaw cycles minimized to preserve the folded structure. These are general handling principles for recombinant research proteins rather than claims about any one preparation, and the documentation for a given standard should be the reference of record for its own conditions.
What IGF-1 LR3 Is Studied For (Chemistry Only)
In a research-chemistry context, IGF-1 LR3 is of interest because it is a well defined model for studying how targeted edits change a folded growth-factor protein. The N-terminal extension and the Arg3 substitution let chemists examine how surface charge and an added tail affect solubility, binding-partner association, and chromatographic behavior relative to native IGF-1, and the analog serves as a well characterized reference point when validating expression and analytical methods on related IGF proteins.
That framing is deliberately limited to the bench. These materials are reference standards for laboratory research only, and nothing here describes or implies any human or veterinary use or outcome. The value of IGF-1 LR3 to a research chemist is as a chemistry subject, an engineered member of the IGF family whose behavior under expression, folding, analysis, and storage is well understood and worth knowing in detail.
This overview is provided for laboratory and research use only. It is educational chemistry reference material and is not for human or veterinary consumption. Buyers are responsible for compliance with all applicable laws and regulations.
What does the "LR3" in IGF-1 LR3 mean?
LR3 stands for Long-Arg3. The analog adds a 13-residue N-terminal extension to native IGF-1 and substitutes arginine for glutamic acid at position 3, giving an 83-residue chain rather than the 70-residue native sequence. These two edits are what distinguish IGF-1 LR3 from native IGF-1 on paper.
How is IGF-1 LR3 made, by solid-phase synthesis or recombinant expression?
At 83 residues with three disulfide bonds, IGF-1 LR3 is produced by recombinant expression rather than solid-phase peptide synthesis. The coding sequence is expressed in a host cell, then the protein is recovered, oxidatively refolded to install the disulfide pattern, and purified. Solid-phase synthesis is reserved for the shorter peptides in the catalog.
How is the identity and purity of IGF-1 LR3 confirmed?
Identity and purity are established with reversed-phase HPLC and mass spectrometry. HPLC reports the purity figure and separates the target from related species, while mass spectrometry confirms that the measured mass matches the expected mass for the correctly folded 83-residue analog. The two methods are read together.
How should IGF-1 LR3 reference standard be stored?
As a lyophilized solid it is kept cold, dry, and out of light, with long-term storage at freezer temperatures and the vial allowed to reach room temperature before opening. Once reconstituted, the solution is held cold, used within a short window, and freeze-thaw cycles are minimized to preserve the folded structure.